All Topics

Subscribe
Article
Genus Claiming (Including Means Plus Function “MPF” Claiming) In Biotech And Pharma: Doctrinal Trajectory And Drafting Strategies
Finnegan attorney Chiaki Kobayashi explores the complex landscape of genus claiming in biotechnology and pharmaceutical patents, examining doctrinal developments and practical drafting approaches. The article, edited by partner John D. Livingstone, provides strategic guidance for navigating means-plus-function claiming methodologies in life sciences intellectual property.
Japan IP
FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Article
The PTAB Under The Squires Administration: New Trends In Discretionary Denial And Implications For Corporate Practice
Finnegan attorneys Naoki Yoshida and Chiaki Kobayashi examine emerging patterns in discretionary denial practices at the Patent Trial and Appeal Board under the Squires Administration, analyzing their impact on corporate intellectual property strategy and practice. This article, published in the Japan Intellectual Property Association's journal, explores how recent administrative changes are reshaping PTAB proceedings and what corporate practitioners need to know to adapt their IP management approaches.
Japan IP
FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Article
Japan Arrests A Nyaa "First Seeder" Going After The Source, Not The Site
Japanese police have arrested an alleged first uploader on Nyaa, the torrent index at the heart of anime piracy, marking a strategic shift from blocking sites to targeting source distributors. Using attribution tools developed under CODA's Cross-Border Enforcement Project, investigators identified and detained a Kanagawa resident suspected of seeding an NHK drama and numerous other works. This case signals a new enforcement approach focused on chokepoints in the distribution chain rather than endless domain
Japan IP
R
Rouse
Article
Navigating Japan's Foreign Investment Rules: Key Requirements And The 2026 Reform Update
Japan's Foreign Exchange and Foreign Trade Act amendments, promulgated in June 2026, introduce significant changes to foreign direct investment screening procedures. These modifications expand regulatory oversight to include indirect acquisitions, mandate reporting of risk mitigation measures, and grant authorities enhanced powers to address national security concerns even after transactions are completed.
Japan Government
WL
Withers LLP
See more